Systemic thrombolytic therapy after recent abdominal aortic aneurysm repair: An absolute contraindication?

Mayo Clinic Proceedings

Volumn 78, Issue 1, 2003, Pages 99-102

  Cable, David G ^a   Cherry, Kenneth J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACRON; HEPARIN; RECOMBINANT PLASMINOGEN ACTIVATOR;

ABDOMEN; ABDOMINAL AORTA ANEURYSM; AGED; ANEURYSM SURGERY; ARTICLE; BLEEDING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DACRON VASCULAR PROSTHESIS; DEEP VEIN THROMBOSIS; FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; LUNG EMBOLISM; MALE; PELVIS; SURVIVAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037215072     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.1.99     Document Type: Article

References (22)

1. Wald DS. Perceived contraindications to thrombolytic treatment in acute myocardial infarction: A survey at a teaching hospital. J Accid Emerg Med. 1998;15:329-331.
2. Pope M, Kalman PG. Aortic transgraft hemorrhage after systemic thrombolytic therapy. Ann Vasc Surg. 1997;11:292-294.
3. Ward AS, Cripps N. Remote transgraft hemorrhage complicating thrombolysis with tissue plasminogen activator [letter]. AJR Am J Roentgenol. 1993;161:1335-1336.
4. Perler BA, Kinnison M, Halden WJ. Transgraft hemorrhage: A serious complication of low-dose thrombolytic therapy. J Vasc Surg. 1986;3:936-938.
5. Rabe FE, Becker GJ, Richmond BD, et al. Contrast extravasation through Dacron grafts: A sequela of low-dose streptokinase therapy. AJR Am J Roentgenol. 1982;138:917-920.
6. Sequeira MJ, Shiralkar S, Edwards AT, Lewis MH. Systemic thrombolysis causing anastomotic dehiscence of an aortobifemoral graft. Ann R Coll Surg Engl. 1998;80:343-346.
7. Irvine C, Whyman M. Systemic thrombolysis causing anastomotic dehiscence of an aortobifemoral graft [letter]. Ann R Coll Surg Engl. 1999;81:72.
8. London NJ, Williams B, Stein A. Systemic thrombolysis causing haemorrhage around a prosthetic abdominal aortic graft. BMJ. 1993;306:1530-1531.
9. Becker GJ, Holden RW, Rabe FE. Contrast extravasation from a Gore-Tex graft: A complication of thrombolytic therapy. AJR Am J Roentgenol. 1984;142:573-574.
10. Anderson DR, Levine MN. Thrombolytic therapy for the treatment of acute pulmonary embolism. CMAJ. 1992;146:1317-1324.
11. Angelides NS, Nicolaides AN, Fernandes J, Gordon-Smith I, Bowers R, Lewis JD. Deep venous thrombosis in patients having aortoiliac reconstruction. Br J Surg. 1977;64:517-518.
12. Satiani B, Kuhns M, Evans WE. Deep venous thrombosis following operations upon the abdominal aorta. Surg Gynecol Obstet. 1980;151:241-245.
13. Reilly MK, McCabe CJ, Abbott WM, et al. Deep venous thrombophlebitis following aortoiliac reconstructive surgery. Arch Surg. 1982;117:1210-1211.
14. Olin JW, Graor RA, O'Hara P, Young JR. The incidence of deep venous thrombosis in patients undergoing abdominal aortic aneurysm resection. J Vasc Surg. 1993;18:1037-1041.
15. Killewich LA, Aswad MA, Sandager GP, Lilly MP, Flinn WR. A randomized, prospective trial of deep venous thrombosis prophylaxis in aortic surgery. Arch Surg. 1997;132:499-504.
16. Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ. 1991;302: 709-711.
17. Haggart PC, Adam DJ, Ludman PF, Ludman CA, Bradbury AW. Myocardial injury and systemic fibrinolysis in patients undergoing repair of ruptured abdominal aortic aneurysm: A preliminary report. Eur J Vasc Endovasc Surg. 2001;21:529-534.
18. Murphy JM, Mulvihill N, Mulcahy D, Foley B, Smiddy P, Molloy MP. Percutaneous catheter and guidewire fragmentation with local administration of recombinant tissue plasminogen activator as a treatment for massive pulmonary embolism. Eur Radiol. 1999; 9:959-964.
19. Stock KW, Jacob AL, Schnabel KJ, Bongartz G, Steinbrich W. Massive pulmonary embolism: Treatment with thrombus fragmentation and local fibrinolysis with recombinant human-tissue plasminogen activator. Cardiovasc Intervent Radiol. 1997;20:364-368.
20. Forster A, Wells P. Tissue, plasminogen activator for the treatment of deep venous thrombosis of the lower extremity: A systematic review. Chest. 2001;119:572-579.
21. Verstraete M, Miller GA, Bounameaux H, et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation. 1988;77:353-360.
22. Trudell LA, Whittemore AD, Sunwoo MH. The performance of commercially available sealed Dacron vascular grafts in intraarterial thrombolytic therapy. ASAIO J. 1995;41:M633-M635.